Search details
1.
Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons.
Proc Natl Acad Sci U S A
; 118(22)2021 06 01.
Article
in English
| MEDLINE | ID: mdl-34035170
2.
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort.
Alzheimers Dement
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38747525
3.
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
Alzheimers Dement
; 20(3): 1988-1999, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38183363
4.
Novel avenues of tau research.
Alzheimers Dement
; 20(3): 2240-2261, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38170841
5.
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
Alzheimers Dement
; 19(4): 1403-1414, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36152307
6.
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
Alzheimers Dement
; 19(6): 2585-2594, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36571821
7.
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
Alzheimers Dement
; 19(9): 4127-4138, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37279390
8.
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
Alzheimers Dement
; 19 Suppl 9: S29-S41, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37653686
9.
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimers Dement
; 19 Suppl 9: S89-S97, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37491599
10.
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
Alzheimers Dement
; 19 Suppl 9: S115-S125, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37491668
11.
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimers Dement
; 19 Suppl 9: S98-S114, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37690109
12.
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
Alzheimers Dement
; 19 Suppl 9: S42-S48, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37296082
13.
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimers Dement
; 19 Suppl 9: S8-S18, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37256497
14.
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
Alzheimers Dement
; 19 Suppl 9: S64-S73, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37801072
15.
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
Alzheimers Dement
; 19 Suppl 9: S74-S88, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37850549
16.
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
Brain
; 144(9): 2826-2836, 2021 10 22.
Article
in English
| MEDLINE | ID: mdl-34077494
17.
Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
Alzheimers Dement
; 18(4): 602-611, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34310832
18.
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aß42/Aß40 and p-tau.
Alzheimers Dement
; 18(2): 283-293, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34151519
19.
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
Alzheimers Dement
; 18(8): 1484-1497, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34845818
20.
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
Mov Disord
; 36(3): 767-771, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33285015